These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30706017)

  • 1. Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions.
    Solanki AA; Mysz ML; Patel R; Surucu M; Kang H; Plypoo A; Bajaj A; Korpics M; Martin B; Hentz C; Gupta G; Farooq A; Baldea KG; Pawlowski J; Roeske J; Flanigan R; Small W; Harkenrider MM
    Adv Radiat Oncol; 2019; 4(1):103-111. PubMed ID: 30706017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.
    Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P
    Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial.
    Tissaverasinghe S; Crook J; Bachand F; Batchelar D; Hilts M; Araujo C; Anderson D; Bainbridge T; Farnquist B
    Brachytherapy; 2019; 18(3):299-305. PubMed ID: 30795889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional vs machine learning-based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial.
    Nicolae A; Semple M; Lu L; Smith M; Chung H; Loblaw A; Morton G; Mendez LC; Tseng CL; Davidson M; Ravi A
    Brachytherapy; 2020; 19(4):470-476. PubMed ID: 32317241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer.
    Yang R; Zhao N; Liao A; Wang H; Qu A
    Med Dosim; 2016; 41(3):236-41. PubMed ID: 27400663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
    Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
    Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live implant dosimetry may be an effective replacement for postimplant computed tomography in localized prostate cancer patients receiving low dose rate brachytherapy.
    Roshan D; Joyce K; Woulfe P; Gorakati PR; Stock R; Sullivan FJ
    Brachytherapy; 2021; 20(4):873-882. PubMed ID: 33840634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.
    Dhere VR; Fischer-Valuck BW; Goyal S; Liu Y; Morgan TM; Ghavidel E; Moghanaki DM; Hershatter BW; Patel PR; Jani AB; Godette KD; Rossi PJ; Patel SA
    Brachytherapy; 2021; 20(6):1130-1138. PubMed ID: 34417136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative dosimetrical analysis of intensity-modulated arc therapy, CyberKnife therapy and image-guided interstitial HDR and LDR brachytherapy of low risk prostate cancer.
    Fröhlich G; Ágoston P; Jorgo K; Stelczer G; Polgár C; Major T
    Rep Pract Oncol Radiother; 2021; 26(2):196-202. PubMed ID: 34211769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
    Lin L; Patel RR; Thomadsen BR; Henderson DL
    Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of treatment planning techniques for low-dose-rate (LDR) prostate brachytherapy.
    Connolly D; Sands G; Winter H; Foley MJ; Kleefeld C
    Brachytherapy; 2021; 20(2):410-419. PubMed ID: 33234407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
    King CR
    Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK & Ireland Prostate Brachytherapy Practice Survey 2014-2016.
    Corey G; Yoosuf ABM; Workman G; Byrne M; Mitchell DM; Jain S
    J Contemp Brachytherapy; 2018 Jun; 10(3):238-245. PubMed ID: 30038644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose Distribution of High Dose-Rate and Low Dose-Rate Prostate Brachytherapy at Different Intervals-Impact of a Hydrogel Spacer and Prostate Volume.
    Haddad H; Hermani H; Hanitzsch H; Heidrich A; Pinkawa M
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a High-Dose-Rate Prostate Brachytherapy Program With Real-Time Ultrasound-Based Planning: Initial Safety, Quality, and Outcome Results.
    Zhang H; Kang S; Ali N; Baran A; Bylund K; Gentile D; Previte G; Matloubieh A; Gray A; Marou N
    Adv Radiat Oncol; 2020; 5(3):388-395. PubMed ID: 32529132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.